Skip to main content
. 2021 Aug 5;12:720571. doi: 10.3389/fimmu.2021.720571

Figure 4.

Figure 4

The proportions of the anti-BCMA CAR-T cells in the therapy. (A, B). The proportions of anti-BCMA-CAR T cells in CD3+ T cells in peripheral blood in the two group of patients. (C, D). There was no difference in the median expansion peak of the anti-BCMA CAR-T cells in CD3+ T cells in peripheral blood in the two group of patients (P= 0.438). (E). In Ptwith 7, the highest anti-BCMA CAR-T cell expression in peripheral blood was 62.4%, the level of anti-BCMA CAR-T cells in her pleural effusion was 24.03%.